FIELD: pharmacology.
SUBSTANCE: disclosed is a method of testing medicinal substances for belonging to substrates of a polypeptide transporting organic anions 1B1, involving the use of a human embryonic kidney cell line transformed with type 5 adenovirus, version 293, and a human embryonic kidney cell line transformed with type 5 adenovirus, version 293, which have been further transfected with a gene encoding a polypeptide transporting organic anions 1B1 with an attached green fluorescent protein, incubating cells with a transport medium containing a test substance in a final concentration of 1 mcM, for 5 minutes and determining the concentrations of this substance in cell lysates, wherein if concentration of test substance in lysate of human embryonic kidney cells transformed by type 5 adenovirus, version 293, which were additionally transfected with a gene coding a polypeptide transporting organic anions 1B1 with attached green fluorescent protein higher than its concentration in human embryonic kidney cell lysate transformed with adenovirus type 5, version 293, 2 and more times test substance is a substrate of a polypeptide which transports organic anions 1B1.
EFFECT: invention provides an accessible and effective method for assessing the belonging of medicinal substances to substrates of a polypeptide transporting organic anions 1B1.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INCREASING AMOUNT OF POLYPEPTIDE TRANSPORTING ORGANIC ANIONS 1B1 (OATP1B1) | 2024 |
|
RU2823925C1 |
REPORTER MONOCLONAL CELL LINE HEK-293/5-HT4R, EXPRESSING MURINE RECOMBINANT SEROTONIN RECEPTOR TYPE 5HT4 | 2022 |
|
RU2817234C2 |
APPLICATION OF EDG2 RECEPTOR ON MODEL OF CARDIO-VASCULAR COLLAPSE IN ANIMALS | 2003 |
|
RU2337963C2 |
METHOD OF EVALUATING BIOACTIVITY OF CHEMICAL COMPOUNDS | 2013 |
|
RU2556823C2 |
APPLICATION OF PAK INHIBITOR FOR ARTHROPATHY TREATMENT | 2004 |
|
RU2360696C2 |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF KIDNEY CANCER | 2017 |
|
RU2752322C2 |
EUKARYOTIC CELL LINE | 2018 |
|
RU2776531C2 |
PROMOTER FOR TISSUE-SPECIFIC GENE EXPRESSION IN TERMINAL MAMMAL TISSUES | 2010 |
|
RU2459870C2 |
METHOD FOR PREDICTING THE VOLUME OF SURGICAL INTERVENTION AND CORRECTION OF POSTOPERATIVE HYPOTHYROIDISM IN PATIENTS WITH TOXIC FORMS OF GOITER | 2021 |
|
RU2774691C1 |
GASTROINTESTINAL PROLIFERATIVE FACTOR AND ITS APPLICATIONS | 2005 |
|
RU2343158C2 |
Authors
Dates
2024-03-11—Published
2023-07-25—Filed